Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

JEF vs NMR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 9–1 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: JEF 2 – 4 NMR Matrix Metrics: JEF 1 – 9 NMR

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Jefferies Financial Group Inc. (JEF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JEF carries a Unified Composite Score of 31.3/100 (SELL) at $42.53 (9.7x Forward P/E, 14.0% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin).

  • Technical & Structure Timing Caution: JEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.6); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About JEF vs NMR
JEF NYSE
Jefferies Financial Group Inc.
Security Brokers, Dealers & Flotation Companies
$42.53
-2.79% 1D
Market Cap $10.5B
TTM Revenue $8.51B
Forward P/E 9.7x
Beta / 30D Vol 1.31β · 52% Vol
Unified Composite Score
31.3 / 100 SELL
Tech 21.0 Fund 44.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 38
RSI-14: 37.6 · SMA20: $46.88 · SMA50: $46.87
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.68% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68

6-Pillar Scorecard Institutional Category Breakdown (JEF 2 – 4 NMR)

Columns: Metric · JEF · NMR
1. Valuation Multiples NMR
Forward P/E 9.7x 12.7x
Trailing P/E 12.2x 11.2x
PEG Ratio 1.09x 0.81x
EV / Revenue 2.5x 1.9x
2. Growth & Scale NMR
Revenue Growth (YoY) +8.5% +17.9%
Earnings Growth (YoY) +17.9% +13.6%
TTM Revenue (USD) $8.51B $14.9B
Market Cap $10.5B $28.3B
3. Profitability & Quality NMR
Gross Margin 82.6% 77.4%
Operating Margin 14.0% 25.1%
Net Profit Margin 11.0% 17.1%
Return on Equity (ROE) 8.6% 11.5%
4. Balance Sheet & Cash Flow JEF
Cash Generation (TTM) $4.20B N/A
Cash Flow Margin 49.3% N/A
Net Cash / Leverage $10.5B Net Debt (2.55x D/E) $8.17 Book/Sh · 11.5% ROE
Dividend Yield 3.46% 3.34%
5. Options & Positioning NMR
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 42.4% (43rd %ile) 30.7% (<1st %ile)
Put/Call OI Skew 11.86x (Put-Skewed) Thin ADR Chain
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat JEF
OpEx & R&D Intensity 68.6% of Rev ($5.84B) 52.3% of Rev ($7.77B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: JEF (1) vs NMR (9)
Institutional Metric JEF NMR Criterion Row Edge
Market Capitalization
Scale
$10.5B $28.3B Larger Scale NMR
Trailing P/E Ratio
Valuation
12.2x 11.2x Lower Multiple NMR
Forward P/E Ratio
Valuation
9.7x 12.7x Lower Multiple JEF
Revenue Growth (YoY)
Growth
+8.5% +17.9% Higher Growth NMR
Operating Margin (TTM)
Profitability
14.0% 25.1% Higher Margin NMR
Net Profit Margin
Profitability
11.0% 17.1% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
8.6% 11.5% Higher ROE NMR
52-Week Range Position
Momentum
22% ($36–$67) 61% ($7–$11) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.31β · 52% Vol 1.03β · 29% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
31.3 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite NMR
Trailing 12M Revenue (USD)
Operating Scale
$8.51B $14.9B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
82.6% 77.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.09x PEG · 2.5x EV/Rev 0.81x PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$4.20B ($10.5B Net Debt (2.55x D/E)) N/A ($8.17 Book/Sh · 11.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +4.86 pp
JEF: -2.45% · NMR: +2.41%
3M Horizon NMR +18.79 pp
JEF: -20.58% · NMR: -1.79%
6M Horizon NMR +33.46 pp
JEF: -16.71% · NMR: +16.75%
1Y Horizon NMR +49.75 pp
JEF: -23.36% · NMR: +26.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JEF vs NMR. Trailing 12-month operating profitability (JEF 14.0% vs NMR 25.1%) and valuation multiples (JEF 9.7x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.

JEF ADR TTM Benchmark FX-Normalized USD
TTM Revenue$8.51B
Gross Margin82.6%
Op. Margin14.0%
ROE / Fwd P/E8.6% · 9.7x
NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
JEF BREAKDOWN
108d in phase · OBV DISTRIBUTION
Current IV 42.4%
IV Percentile 43rd %ile
Put/Call OI Skew 11.86x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact JEF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $43.75 · IV 44.4%

JEF Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($4,375)

Compare $4,375 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 44.4% ATM IV.

PUT-WALL MONTHLY INCOME Liq B

Dec 18 $40 / $35 Bull Put Spread

Sell 1x $40P · Buy 1x $35P · 32d

Net Entry $94 Credit
Max Credit / Yield +$94 (+23.2% RoM)
Max Risk / Buffer -10.7% Cushion ($406 Mgn)
5d Edge & Liquidity 76% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $45 / $40 Bear Put Spread

Buy 1x $45P · Sell 1x $40P · 32d

Net Entry $193 Debit
T+5d @ -5% Drop +$73 (+38%)
Max Risk / Buffer $193 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
JEF Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $10.5B market capitalization and 14.0% operating margin.
OpEx & R&D Reinvestment 68.6% of Rev ($5.84B)
90D Engineering Disclosures 0 Published
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published

Investor FAQ JEF vs NMR Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Jefferies Financial Group Inc. (JEF) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). JEF carries a Unified Composite Score of 31.3/100 (SELL) at $42.53 (9.7x Forward P/E, 14.0% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin). Technical & Structure Timing Caution: JEF is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 37.6); meanwhile NMR trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

NMR leads the Growth & Scale pillar: JEF posts +8.5% YoY revenue growth and +17.9% YoY earnings growth on $8.51B TTM revenue (82.6% gross margin, 14.0% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, JEF generates $8.51B in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, JEF deploys 68.6% of Rev ($5.84B) (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.

NMR screens cheaper on headline valuation multiples. JEF trades at 9.7x Forward P/E, 12.2x Trailing P/E, 1.09x PEG, and 2.5x EV/Revenue (49.3% FCF margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JEF (8.6% ROE) versus NMR (11.5% ROE) capital efficiency.

In options market volatility and institutional positioning, JEF carries 42.4% implied volatility (43rd %ile, Balanced (25th–60th %ile)), a 11.86x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.31β · 52% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.